SALT LAKE CITY (ABC4 News) — A study led in part by a cancer researcher at the Huntsman Cancer Institute says early cancer screenings in patients with Li-Fraumeni Syndrome often result in an increased lifespan and are cost-effective forms of healthcare.
Researchers say they used a model that showed how those who received early screening carried an incremental medical cost of $17,000 per year.
“One of the biggest clinical challenges we have with early cancer screenings for our LFS patients is receiving insurance approval. Hopefully, we can use this research to show that, not only does early cancer screening save lives, but it is also cost effective for LFS patients.” said Joshua Schiffman, a cancer researcher.
The research team says it will continue conducting research on the cost-effectiveness of early detection.